Literature DB >> 21640971

Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.

Dominique Guerrot1, Monique Kerroch, Sandrine Placier, Sophie Vandermeersch, Claire Trivin, Mouna Mael-Ainin, Christos Chatziantoniou, Jean-Claude Dussaule.   

Abstract

The interactions between tubulointerstitial infiltrating cells and the extracellular matrix play an important role in regulating renal fibrosis. Discoidin domain receptor 1 (DDR1) is a nonintegrin tyrosine kinase receptor for collagen implicated in cell adhesion, proliferation, and extracellular matrix remodeling. We have previously demonstrated that transgenic mice lacking DDR1 are protected from hypertension-associated renal fibrosis. The purpose of this study was to determine the role of DDR1 in renal inflammation and fibrosis related to primitive tubulointerstitial injury. After 12 days of unilateral ureteral obstruction (UUO), kidney histopathologic and real-time quantitative PCR analyses were performed in DDR1(-/-) and wild-type mice. DDR1 expression was strongly increased in the obstructed kidney. Wild-type mice developed important perivascular and interstitial inflammation and fibrosis. In comparison, DDR1(-/-) mice displayed reduced accumulation of fibrillar collagen and transforming growth factor β expression. F4/80(+) cell count and proinflammatory cytokines were remarkably blunted in DDR1(-/-) obstructed kidneys. Leukocyte rolling and adhesion evaluated by intravital microscopy were not different between DDR1(-/-) and wild-type mice. Importantly, macrophages isolated from DDR1(-/-) mice presented similar M1/M2 polarization but displayed impaired migration in response to monocyte chemoattractant protein-1. Together, these data suggest that DDR1 plays an important role in the pathogenesis of renal disease via enhanced inflammation. Inhibition of DDR1 expression or activity may represent a novel therapeutic target against the progression of renal diseases.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640971      PMCID: PMC3123843          DOI: 10.1016/j.ajpath.2011.03.023

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair.

Authors:  G Hou; W Vogel; M P Bendeck
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

Authors:  Hans-Joachim Anders; Volker Vielhauer; Michael Frink; Yvonne Linde; Clemens D Cohen; Simone M Blattner; Matthias Kretzler; Frank Strutz; Matthias Mack; Hermann-Josef Gröne; James Onuffer; Richard Horuk; Peter J Nelson; Detlef Schlöndorff
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice.

Authors:  Bärbel Lange-Sperandio; Francois Cachat; Barbara A Thornhill; Robert L Chevalier
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

4.  Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism.

Authors:  J J Boffa; P L Tharaux; S Placier; R Ardaillou; J C Dussaule; C Chatziantoniou
Journal:  Circulation       Date:  1999-11-02       Impact factor: 29.690

5.  Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes.

Authors:  Volker Vielhauer; Hans-Joachim Anders; Matthias Mack; Josef Cihak; Frank Strutz; Manfred Stangassinger; Bruno Luckow; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2001-06       Impact factor: 10.121

Review 6.  Discoidin domain receptor 1: a new class of receptor regulating leukocyte-collagen interaction.

Authors:  Teizo Yoshimura; Wataru Matsuyama; Hidenobu Kamohara
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development.

Authors:  W F Vogel; A Aszódi; F Alves; T Pawson
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

8.  Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices.

Authors:  H Kamohara; S Yamashiro; C Galligan; T Yoshimura
Journal:  FASEB J       Date:  2001-10-15       Impact factor: 5.191

9.  Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src.

Authors:  Katherine Kun Lu; Dan Trcka; Michelle P Bendeck
Journal:  Cardiovasc Pathol       Date:  2010-01-25       Impact factor: 2.185

10.  Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells.

Authors:  M Jönsson; T Andersson
Journal:  J Cell Sci       Date:  2001-06       Impact factor: 5.285

View more
  33 in total

Review 1.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

Review 2.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

Review 3.  Discoidin domain receptor-1 and periostin: new players in chronic kidney disease.

Authors:  Carlo Alfieri; Panagiotis Kavvadas; Paola Simonini; Masami Ikehata; Jean Claude Dussaule; Christos E Chadjichristos; Maria Pia Rastaldi; Piergiorgio Messa; Christos Chatziantoniou
Journal:  Nephrol Dial Transplant       Date:  2015-03-31       Impact factor: 5.992

4.  Novel Targets for Therapy of Renal Fibrosis.

Authors:  Niki Prakoura; Juliette Hadchouel; Christos Chatziantoniou
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

5.  Discoidin domain receptor 2 regulates neutrophil chemotaxis in 3D collagen matrices.

Authors:  Philippe V Afonso; Colin P McCann; Senta M Kapnick; Carole A Parent
Journal:  Blood       Date:  2012-12-11       Impact factor: 22.113

6.  Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.

Authors:  Chiara Ambrogio; Gonzalo Gómez-López; Mattia Falcone; August Vidal; Ernest Nadal; Nicola Crosetto; Rafael B Blasco; Pablo J Fernández-Marcos; Montserrat Sánchez-Céspedes; Xiaomei Ren; Zhen Wang; Ke Ding; Manuel Hidalgo; Manuel Serrano; Alberto Villanueva; David Santamaría; Mariano Barbacid
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

7.  Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.

Authors:  Clothilde Roche; Dominique Guerrot; Najah Harouki; Thomas Duflot; Marie Besnier; Isabelle Rémy-Jouet; Sylvanie Renet; Anaïs Dumesnil; Annie Lejeune; Christophe Morisseau; Vincent Richard; Jeremy Bellien
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-05-27       Impact factor: 3.072

Review 8.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

Review 9.  Cell Receptor-Basement Membrane Interactions in Health and Disease: A Kidney-Centric View.

Authors:  Corina M Borza; Xiwu Chen; Roy Zent; Ambra Pozzi
Journal:  Curr Top Membr       Date:  2015       Impact factor: 3.049

Review 10.  Discoidin domain receptors in disease.

Authors:  Corina M Borza; Ambra Pozzi
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.